Cardiome Pharma Corp. (Nasdaq: CRME) announced that pricing approval and national reimbursement for both ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE